Pharma Marketing Network

In this 2-minute audio snippet, Edward M. Zabrek, M.D., F.A.C.O.G., Medical Editor, SmartPhone Magazine and iPhone Life Magazine and Renee McLeod, PhD, APRN, BC, CPNP-PC, Clinical Professor, Arizona State University College of Nursing & Healthcare Innovation, Office of Transformational Technologies & Organizations, discuss mobile information technology habits of healthcare professionals and how pharmaceutical marketers can leverage the iPhone/Smartphone channel to educate and market to HCPs about their brands.

In this 1-minute audio snippet, Sydney Wolfe, MD, formerly head of Public Citizen, explains why you should wait at least seven years from the date of release to take any new drug unless it is one of those rare ‘breakthrough’ drugs that offers you a documented therapeutic advantage over older proven drugs.

In this 4-minute audio snippet, Maureen Winigrad and John Griffith of Centric Infographics, give an update on the impact of the Managing Epilepsy & Seizures infographic campaign they launched in 2013 and introduce a new companion piece for the #Dare to Say SUDEP campaign.

At his April 5, 2017, Senate Hearing, Dr. Scott Gottlieb, President Trump's nominee for FDA Commissioner, responded to Massachusetts Senator Elizabeth Warren's concern about his commitment to FDA's basic safety mission.

The FDA has a lot of hurdles to overcome in its effort to stem the current opioid addiction epidemic it helped to create.

In this 4-minute audio snippet, Roland Andersson, Director for Accenture's Life Sciences R&D practice, and Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly, discuss the Transcelerate Biopharma initiative, the goals of which are to increase compliance and the productivity of clinical trials.

In this 5-minute audio snippet, Thomas P. Stossel, M.D., visiting scholar at the American Enterprise Institute for Public Policy Research, talks about what he calls the 'Conflict-of-Interest Narrative' or Myth, which is the subject of his new book, PharmaPhobia.

In this 3-minute audio snippet, Todd D. Clark, President of Value of Insight Consulting and the author of pharmahandbook and generichandbook, discusses a few ideas on how the pharmaceutical industry can avoid the slow-growth trap in the U.S. market.

Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition, warns of FDA mobile guidance that the drug industry should be concerned about: new guidelines regarding FDA's regulation of clinical decision support (CDS) software.

In this 2.5-minute audio snippet, Len Starnes, a renowned digital healthcare consultant, talks about the transformation of medical congresses from the physical to the virtual. Starnes touches on the challenges and gives an example of how one medical society is overcoming them.